3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Blood Specimen Collection
5
Drug Therapy
3
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Carboplatin
2
Biopsy, Large-Core Needle
2
Biopsy
2
toripalimab
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
atezolizumab
1
Zoledronic Acid
1
Urine Specimen Collection
1
Prophylactic Mastectomy
1
Paracentesis
1
Neuropsychological Tests
1
Mifepristone
1
Medicine, Chinese Traditional
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Doxorubicin
1
DNA
1
Cyclophosphamide
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Prophylactic Mastectomy
×
Clear all
NCT05062174
2022-12-15
Breast Cancer BRCA1 Carriers: a Pilot Study
Indiana University
Withdrawn